JP2011507855A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507855A5
JP2011507855A5 JP2010539511A JP2010539511A JP2011507855A5 JP 2011507855 A5 JP2011507855 A5 JP 2011507855A5 JP 2010539511 A JP2010539511 A JP 2010539511A JP 2010539511 A JP2010539511 A JP 2010539511A JP 2011507855 A5 JP2011507855 A5 JP 2011507855A5
Authority
JP
Japan
Prior art keywords
connexin
composition
agent
polynucleotide
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507855A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/014019 external-priority patent/WO2009085268A2/en
Publication of JP2011507855A publication Critical patent/JP2011507855A/ja
Publication of JP2011507855A5 publication Critical patent/JP2011507855A5/ja
Pending legal-status Critical Current

Links

JP2010539511A 2007-12-21 2008-12-22 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用 Pending JP2011507855A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US888807P 2007-12-21 2007-12-21
PCT/US2008/014019 WO2009085268A2 (en) 2007-12-21 2008-12-22 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014152828A Division JP2014208699A (ja) 2007-12-21 2014-07-28 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用

Publications (2)

Publication Number Publication Date
JP2011507855A JP2011507855A (ja) 2011-03-10
JP2011507855A5 true JP2011507855A5 (OSRAM) 2013-04-25

Family

ID=40824953

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010539511A Pending JP2011507855A (ja) 2007-12-21 2008-12-22 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用
JP2014152828A Pending JP2014208699A (ja) 2007-12-21 2014-07-28 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014152828A Pending JP2014208699A (ja) 2007-12-21 2014-07-28 外科的癒着の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた抗コネキシンペプチドの使用

Country Status (7)

Country Link
US (1) US20110245184A1 (OSRAM)
EP (1) EP2237796A2 (OSRAM)
JP (2) JP2011507855A (OSRAM)
AU (1) AU2008343839A1 (OSRAM)
CA (1) CA2710223A1 (OSRAM)
WO (1) WO2009085268A2 (OSRAM)
ZA (1) ZA201005215B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006257283A1 (en) 2005-02-03 2006-12-21 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
CN102920996A (zh) * 2007-12-11 2013-02-13 科达治疗公司 受损伤口愈合的药物组合物
AU2008343841A1 (en) 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of inhibitors of connexin43 for treatment of fibrotic conditions
MX351881B (es) 2012-03-01 2017-11-01 Firststring Res Inc Geles tópicos que contienen péptidos de alfa-conexina c- terminal (act).
US9156896B2 (en) * 2013-03-15 2015-10-13 Coda Therapeutics, Inc. Wound healing compositions and treatments
WO2015139047A2 (en) * 2014-03-14 2015-09-17 Coda Therapeutics Treatment of resistant lesions
US10465188B2 (en) 2014-08-22 2019-11-05 Auckland Uniservices Limited Channel modulators
CN105566495B (zh) * 2016-01-27 2019-10-22 上海科技大学 一种特异性抑制连接蛋白26的全人抗体
WO2018199777A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs
AU2021364900A1 (en) 2020-10-22 2023-06-08 Xequel Bio, Inc. Peptide formulations and ophthalmic uses thereof
JP6911993B1 (ja) * 2020-12-11 2021-07-28 東洋インキScホールディングス株式会社 抗菌性活性エネルギー線硬化型コーティング組成物、コーティング層、抗菌性部材、および物品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU776512B2 (en) * 1999-01-27 2004-09-09 David Laurence Becker Formulations comprising antisense nucleotides to connexins
JP2005509621A (ja) * 2001-10-17 2005-04-14 ユニバーシティ オブ ウェールズ カレッジ オブ メディスン ギャップ結合ならびにedhf
WO2006006948A2 (en) * 2002-11-14 2006-01-19 Dharmacon, Inc. METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
PL2289535T3 (pl) * 2004-12-21 2018-12-31 Musc Foundation For Research Development Kompozycje i sposoby wspomagania gojenia ran oraz regeneracji tkanek
AU2006257283A1 (en) * 2005-02-03 2006-12-21 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
US8247384B2 (en) * 2006-11-15 2012-08-21 Coda Therapeutics, Inc. Methods and compositions for wound healing
CN102920996A (zh) * 2007-12-11 2013-02-13 科达治疗公司 受损伤口愈合的药物组合物
JP2011506446A (ja) * 2007-12-11 2011-03-03 コーダ セラピューティクス, インコーポレイテッド 損傷した創傷治癒組成物および治療

Similar Documents

Publication Publication Date Title
JP2011507855A5 (OSRAM)
JP2011507861A5 (OSRAM)
JP2011507860A5 (OSRAM)
JP6918724B2 (ja) 急性骨髄性白血病(aml)のための新規併用治療
JP5185826B2 (ja) ウイルス性肝炎の処置
JP2011506447A5 (OSRAM)
US10335455B2 (en) Method for prevention or treatment of intractable inflammatory bowel disease
JP2009522371A5 (OSRAM)
CA2730789A1 (en) Treatment of inflammatory bowel diseases with mammal beta defensins
EA032767B1 (ru) Применение баклофена или его соли для лечения болезни шарко-мари-тусса (смт) и связанного с ней расстройства
EA024523B1 (ru) Фармацевтическая композиция для лечения болезни шарко-мари-тута и родственных с ней расстройств
MX2010013984A (es) Combinacion de pilocarpina y metimazol para tratar la enfermedad de charcot-marie-tooth y trastornos relacionados.
JP2018087228A (ja) がんのためのグルフォスファミド組み合わせ療法
JP2009544585A5 (OSRAM)
KR20120014251A (ko) 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법
KR101628448B1 (ko) 암 치료에 사용하기 위한 베무라페닙 및 인터페론을 포함하는 병용 요법
CN101820887A (zh) 干扰素控释药品以及使用相同药品治疗hcv感染
JP2011507859A5 (OSRAM)
WO2023192916A2 (en) Rna comprising secretomes and methods of their use
WO2009075813A1 (en) Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic t lymphocyte-associated antigen 4 (ctla4)
Bufalari et al. Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo controlled clinical trial
AU782357B2 (en) Treatment of dyskinesia
US20130004459A1 (en) Methods, pharmaceutical compositions and kits for use in the treatment of adult t-cell leukemia/lymphoma
WO2016071431A1 (en) A combination for cancer therapy
US9173918B2 (en) Compositions and methods for the treatment of cardiac surgery-associated acute kidney injury with annexin A1 peptide